Literature DB >> 23223012

The Trend in Morning Levels of Salivary Cortisol in Children With ADHD During 6 Months of Methylphenidate Treatment.

Liang-Jen Wang1, Yu-Shu Huang2,3, Cheng-Cheng Hsiao4, Chih-Ken Chen3,5.   

Abstract

OBJECTIVE: To determine the trend in cortisol levels in children with ADHD treated with methylphenidate (MPH) and nontreated healthy controls over a 6-month period.
METHOD: The morning salivary cortisol levels of 50 patients with ADHD (40 boys and 10 girls, mean age = 7.6 years) and 50 age- and gender-matched healthy controls were measured at baseline and at 1, 3, and 6 months from baseline. The neuropsychological performance of the ADHD patients was measured via administration of the Continuous Performance Test.
RESULTS: The cortisol levels of ADHD patients increased significantly after 1 month of MPH treatment before decreasing to an intermediate level, but were significantly positively correlated with neuropsychological performance throughout the 6-month treatment period. The cortisol levels of the controls did not change significantly over the 6-month period.
CONCLUSION: MPH administration appears to positively influence the functioning of the hypothalamic-pituitary-adrenal axis in ADHD patients.

Entities:  

Keywords:  ADHD; cognitive function; methylphenidate; neurobiology; psychostimulant

Mesh:

Substances:

Year:  2016        PMID: 23223012     DOI: 10.1177/1087054712466139

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  5 in total

1.  Differential Pharmacological Regulation of Sensorimotor Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations.

Authors:  Antonio Ortega-Álvaro; Francisco Navarrete; Auxiliadora Aracil-Fernández; Daniela Navarro; Pere Berbel; Jorge Manzanares
Journal:  Neuropsychopharmacology       Date:  2015-04-21       Impact factor: 7.853

2.  Dysregulation of the cortisol diurnal rhythm following prenatal alcohol exposure and early life adversity.

Authors:  Kaitlyn McLachlan; Carmen Rasmussen; Tim F Oberlander; Christine Loock; Jacqueline Pei; Gail Andrew; James Reynolds; Joanne Weinberg
Journal:  Alcohol       Date:  2016-04-01       Impact factor: 2.405

3.  Deficits in Response Inhibition in Patients with Attention-Deficit/Hyperactivity Disorder: The Impaired Self-Protection System Hypothesis.

Authors:  Thales Vianna Coutinho; Samara Passos Santos Reis; Antonio Geraldo da Silva; Debora Marques Miranda; Leandro Fernandes Malloy-Diniz
Journal:  Front Psychiatry       Date:  2018-01-22       Impact factor: 4.157

4.  Temperament Dimensions and Awakening Cortisol Levels in Attention-Deficit/Hyperactivity Disorder.

Authors:  Alessandra Carta; Isabella Vainieri; Anna-Sophie Rommel; Alessandro Zuddas; Jonna Kuntsi; Stefano Sotgiu; Nicoletta Adamo
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 5.435

5.  Attention-Deficit/Hyperactivity Disorder, Its Pharmacotherapy, and Adrenal Gland Dysfunction: A Nationwide Population-Based Study in Taiwan.

Authors:  Pin-Han Peng; Meng-Yun Tsai; Sheng-Yu Lee; Po-Cheng Liao; Yu-Chiau Shyu; Liang-Jen Wang
Journal:  Int J Environ Res Public Health       Date:  2020-05-25       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.